P. E. M. Fine

1.9k total citations
49 papers, 1.3k citations indexed

About

P. E. M. Fine is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, P. E. M. Fine has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 18 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in P. E. M. Fine's work include Tuberculosis Research and Epidemiology (23 papers), Leprosy Research and Treatment (21 papers) and Mycobacterium research and diagnosis (7 papers). P. E. M. Fine is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Leprosy Research and Treatment (21 papers) and Mycobacterium research and diagnosis (7 papers). P. E. M. Fine collaborates with scholars based in United Kingdom, Malawi and Germany. P. E. M. Fine's co-authors include J. M. Pönnighaus, Laura C. Rodrigues, J. M. Pönnighaus, Lyn Bliss, Amelia C. Crampin, Judith R. Glynn, N. Maine, Jonathan A C Sterne, Emilia Vynnycky and R. J. W. Rees and has published in prestigious journals such as The Lancet, American Journal of Epidemiology and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

P. E. M. Fine

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. E. M. Fine United Kingdom 21 998 576 332 213 151 49 1.3k
Ruby Siddiqui United Kingdom 21 711 0.7× 791 1.4× 304 0.9× 182 0.9× 112 0.7× 41 1.4k
Assan Jaye Gambia 33 1.3k 1.3× 891 1.5× 1.0k 3.1× 88 0.4× 72 0.5× 81 2.8k
Pierre Loulergue France 25 746 0.7× 981 1.7× 235 0.7× 64 0.3× 62 0.4× 61 1.7k
Vladimir Gîlca Canada 26 454 0.5× 1.2k 2.0× 106 0.3× 135 0.6× 94 0.6× 73 1.6k
Marguerite Massinga Loembé Gabon 22 606 0.6× 419 0.7× 314 0.9× 212 1.0× 153 1.0× 59 1.7k
Robin Biellik United States 20 462 0.5× 770 1.3× 180 0.5× 37 0.2× 104 0.7× 49 1.4k
Francisco Averhoff United States 27 611 0.6× 1.9k 3.2× 95 0.3× 83 0.4× 138 0.9× 91 2.5k
J. M. Pönnighaus United Kingdom 23 1.3k 1.3× 829 1.4× 390 1.2× 358 1.7× 13 0.1× 52 1.6k
Julie E. Fischer United States 16 433 0.4× 576 1.0× 114 0.3× 55 0.3× 60 0.4× 35 1.1k
Pauline Waight United Kingdom 31 517 0.5× 2.0k 3.5× 313 0.9× 48 0.2× 198 1.3× 58 2.5k

Countries citing papers authored by P. E. M. Fine

Since Specialization
Citations

This map shows the geographic impact of P. E. M. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. E. M. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. E. M. Fine more than expected).

Fields of papers citing papers by P. E. M. Fine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. E. M. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. E. M. Fine. The network helps show where P. E. M. Fine may publish in the future.

Co-authorship network of co-authors of P. E. M. Fine

This figure shows the co-authorship network connecting the top 25 collaborators of P. E. M. Fine. A scholar is included among the top collaborators of P. E. M. Fine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. E. M. Fine. P. E. M. Fine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Palwasha, Katherine Fielding, Themba Mzembe, et al.. (2016). Risk factors for <I>Mycobacterium tuberculosis</I> infection in 2–4 year olds in a rural HIV-prevalent setting. The International Journal of Tuberculosis and Lung Disease. 20(3). 342–349. 7 indexed citations
2.
Fine, P. E. M., Ben Goldacre, & Andy Haines. (2013). Epidemiology—a science for the people. The Lancet. 381(9874). 1249–1252. 20 indexed citations
3.
Hesseling, Anneke C., Leigh F. Johnson, Heather B. Jaspan, et al.. (2009). Disseminated Bacille Calmette-Guerin Disease in HIV-Infected South African infants/Infection Disseminee Par le Bacille De Calmette-Guerin Chez Les Nourrissons Infectes Par le VIH d'Afrique Du Sud/Infeccion Diseminada Por El Bacilo De Calmette-Guerin En Lactantes Infectados Por El VIH En Sudafrica. Bulletin of the World Health Organization. 87(7). 505. 1 indexed citations
4.
Glynn, Judith R., et al.. (2008). Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi. Sexually Transmitted Infections. 84(5). 356–360. 24 indexed citations
5.
Vynnycky, Emilia, et al.. (2007). Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiology and Infection. 136(7). 943–952. 37 indexed citations
6.
White, Richard G., Emilia Vynnycky, Judith R. Glynn, et al.. (2007). HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiology and Infection. 135(6). 922–932. 30 indexed citations
7.
Warndorff, David K, M.D. Yates, Bagrey Ngwira, et al.. (2000). Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.. PubMed. 4(8). 752–7. 25 indexed citations
8.
Pönnighaus, J. M., et al.. (1996). The epidemiology of pityriasis versicolor in Malawi, Africa. Mycoses. 39(11-12). 467–470. 17 indexed citations
9.
Fine, P. E. M.. (1996). Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.. PubMed. 348(9019). 17–24. 211 indexed citations
10.
Fine, P. E. M., et al.. (1995). Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi. The Lancet. 345(8954). 907–910. 25 indexed citations
11.
Fine, P. E. M., et al.. (1993). A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in Western Kenya. Tubercle and Lung Disease. 74(6). 377–381. 16 indexed citations
12.
Pönnighaus, J. M., P. E. M. Fine, Lyn Bliss, et al.. (1993). The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in Northern Malaŵi. I. Methods of the vaccination phase. Leprosy Review. 64(4). 338–56. 30 indexed citations
13.
Pönnighaus, J. M., P. E. M. Fine, Jonathan A C Sterne, Sebastian Lucas, & A. C. McDOUGALL. (1993). Long-term active surveillance of leprosy suspects - what are the likely returns?. Leprosy Review. 64(1). 25–36. 1 indexed citations
14.
Fine, P. E. M. & Laura C. Rodrigues. (1990). Mycobacterial diseases. The Lancet. 335(8696). 1016–1020. 102 indexed citations
15.
Fine, P. E. M., et al.. (1990). Disabilities in leprosy patients ascertained in a total population survey in Karonga District, Northern Malaŵi. Leprosy Review. 61(4). 366–74. 22 indexed citations
16.
Pönnighaus, J. M., P. E. M. Fine, P.J.K. Gruer, & N. Maine. (1990). The anatomical distribution of single leprosy lesions in an African population, and its implications for the pathogenesis of leprosy. Leprosy Review. 61(3). 242–50. 7 indexed citations
17.
Fine, P. E. M., J. M. Pönnighaus, & N. Maine. (1989). The distribution and implications of BCG scars in northern Malawi.. PubMed. 67(1). 35–42. 62 indexed citations
18.
Fine, P. E. M. & JACQUELINE A CLARKSON. (1988). REFLECTIONS ON THE EFFICACY OF PERTUSSIS VACCINES. The Pediatric Infectious Disease Journal. 7(4). 307–307. 2 indexed citations
19.
Fine, P. E. M., et al.. (1985). Long term effects of exposure to viral infections in utero.. BMJ. 290(6467). 509–511. 25 indexed citations
20.
Anderson, Roy M., Robert M. May, & P. E. M. Fine. (1982). Population biology of infectious diseases : report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin 1982, March 14-19. Springer eBooks. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruby Siddiqui Breakdown of academic impact, for papers by Assan Jaye Breakdown of academic impact, for papers by Pierre Loulergue Breakdown of academic impact, for papers by Vladimir Gîlca Breakdown of academic impact, for papers by Marguerite Massinga Loembé Breakdown of academic impact, for papers by Robin Biellik Breakdown of academic impact, for papers by Francisco Averhoff Breakdown of academic impact, for papers by J. M. Pönnighaus Breakdown of academic impact, for papers by Julie E. Fischer Breakdown of academic impact, for papers by Pauline Waight
Rankless by CCL
2026